Showing results (61-70 of 112) with videos related to

Sort By:
Pageof 12
Cancer Reports (Hoboken, N.J.)|July 28, 2021
Pulmonary surveillance in pediatric hematopoietic stem cell transplant: A multinational multidisciplinary surveyShivanthan Shanthikumar, William A Gower, Matthew Abts, et al.
Annals of the American Thoracic Society|October 15, 2020
Pulmonary Complications of Pediatric Hematopoietic Cell Transplantation. A National Institutes of Health Workshop SummaryRobert F Tamburro, Kenneth R Cooke, Stella M Davies, et al.
The Journal of Clinical Investigation|May 24, 2022
Donor T cell DNMT3a regulates alloreactivity in mouse models of hematopoietic stem cell transplantationYiouli P Ktena, Michael A Koldobskiy, Michael I Barbato, et al.
Blood Advances|September 8, 2018
Immune checkpoint inhibitors as a bridge to allogeneic transplantation with posttransplant cyclophosphamideLaura K Schoch, Kenneth R Cooke, Nina D Wagner-Johnston, et al.
Experimental Hematology|October 11, 2003
Role of CXCR3-induced donor T-cell migration in acute GVHDUlrich Duffner, Bao Lu, Gerhard C Hildebrandt, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 11, 2016
Alternative-Donor Hematopoietic Stem Cell Transplantation with Post-Transplantation Cyclophosphamide for Nonmalignant DisordersOrly R Klein, Allen R Chen, Christopher Gamper, et al.
Pediatric Blood & Cancer|April 23, 2015
Successful hematopoietic cell transplantation in a patient with X-linked agammaglobulinemia and acute myeloid leukemiaRolla F Abu-Arja, Leah R Chernin, Ghada Abusin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 8, 2017
Post-Transplantation Cyclophosphamide after Bone Marrow Transplantation Is Not Associated with an Increased Risk of Donor-Derived MalignancyRobbie G Majzner, Huzefa Mogri, Ravi Varadhan, et al.
Pageof 12